 |
 |
 |
| |
TESAMORELIN (EGRIFTA WR AND EGRIFTA® ) FORMULATIONS: BIOEQUIVALENCE IN HEALTHY PARTICIPANTS
 
|
| |
| |
IDWeek Oct 19-22 Atlanta  
CALDJI C1, MARSOLAIS C1, SICARD E2, DE CHANTAL M1, AND ANSTETT K1
1 Theratechnologies Inc, Montréal, Canada. 2 AltaSciences/Algorithm Pharma, Montréal, Canada




|
| |
|
 |
 |
|
|